Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Mogamulizumab

EU orphan designation number: EU/3/16/1756   
Active ingredient: Mogamulizumab
Indication: Treatment of cutaneous T-cell lymphoma
Sponsor: Kyowa Kirin Limited
Galabank Business Park, Galashiels, TD1 1QH, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page
Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
18/10/2016 Orphan designation EMA/OD/091/16 (2016)6747 of 14/10/2016